One significant challenge in targeting replication is the potential for drug resistance. Cancer cells can develop mutations that enable them to bypass the effects of therapy. Additionally, because therapies targeting replication also affect normal rapidly dividing cells, they can cause side effects such as hair loss, gastrointestinal issues, and bone marrow suppression.
